Amy Mahery - Feb 1, 2024 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-Fact
Stock symbol
CNSP
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
3
Date filed
2/6/2024, 10:26 AM
Next filing
Apr 10, 2024

No securities are beneficially owned.